Indian stocks facing heavy selling pressure due to significant US market exposure are experiencing a downturn amidst escalating recession fears in the US and a looming global economic slowdown. Sectors such as auto, metals, software, and pharma are particularly vulnerable due to concerns surrounding high US import tariffs and potential retaliatory actions. The volatile market conditions are causing investors to reevaluate their positions and adopt a more cautious approach towards stocks with heavy US dependencies. As uncertainties loom over the global economic landscape, Indian companies with exposure to the US market are bracing themselves for potential challenges ahead.